Stock Evaluator: Inspire Medical Systems, Inc. (INSP)

Inspire Medical Systems, Inc. INSP

$50.21 0.19 0.38%
July 31, 2026 4:00:03 PM EST November 10, 2021 Volume: 672,166
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NYSE | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Commentary & Analysis


Financial Summary

Share Statistics INSP Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $1,446.7 $337.2 50%
Shares Out (Mil) 28.7 41.9 36%
Institutional Ownership 98.9% 77.8% 83%
Float (Mil) 25.5 34.7 33%
Beta 0.73 0.85 43%
Avg Daily Volume (000s) 783 278 66%
Price Change
(52-week)
(61.7%) 58.7% 12%
Growth INSP Industry
Median
Percentile
(All Stocks)
Sales (5yr) 51.2% 11.8% 96%
Net Income (5yr) 35.3% (5.8%) 88%
EPS (5yr) 33.4% 11.4% 83
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (17.5%) (16.3%) 40%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 13 14 14
Current EPS ($0.245) $0.903 $1.263
Month Ago EPS ($0.245) $0.906 $1.281
# Rev Up 1 0 2
# Rev Down 0 2 0
Three Months Ago EPS $0.251 $2.032 $2.585
Year/Year Chg (37.8%) (81.5%) (61.3%)
Financials INSP Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $915 $152 50%
Net Income (TTM) (Mil) $131 ($10) 64%
EPS (TTM) $4.504 ($0.500) 85%
Operating Cash Flow (TTM) (Mil) $137 ($2) 55%
Net Cash Flow (TTM) (Mil) $45 $1 70%
Long-Term Debt (Q1) (Mil) $30 $22 35%
Enterprise Value (Q1) (Mil) $954 $304 41%
Valuation INSP Industry
Median
Percentile
(All Stocks)
P/B 1.83 2.80 48%
P/E 11.2 31.1 20%
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) 0.3 1.9 15%
Ratios INSP Industry
Median
Percentile
(All Stocks)
Gross Margin 85.8% 59.1% 92%
Net Margin 14.3% (7.3%) 72%
ROA 16.0% (13.7%) 94%
ROE 18.4% (15.8%) 77%
Liabilities to Assets 13.1% 44.7% 8%
F-Score 7 4 84%

Inspire Medical Systems, Inc. did not pass any screens on 7/31/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors